Akụkọ
-
Ntụle ahịa nke Dulaglutide, Liraglutide na Semaglutide.
Nnukwu ọgwụ Lilly, ụlọ ọrụ America na Novo Nordisk, ụlọ ọrụ Danish, ekwupụtala nke ọma data ahịa nke ngwaahịa ha bụ isi na 2020: Dulaglutide abụrụla TOP1 GLP-1 d ...GỤKWUO -
Hormone uto ọ na-ebelata ma ọ bụ na-eme ka ịka nká ngwa ngwa?
GH/IGF-1 na-ebelata physiologically na afọ, na mgbanwe ndị a na-esonyere ike ọgwụgwụ, muscle atrophy, ụba adipose anụ ahụ, na cognitive deterioration na ndị agadi ... Na 1990, Rudma ...GỤKWUO -
Ntinye ngwaahịa ọhụrụ
Iji nyekwuo ndị ahịa nhọrọ na ụlọ ọrụ peptides ịchọ mma, Gentolex ga-agbakwunye ngwaahịa ọhụrụ na listi ahụ.Ogo dị elu nwere ụdị dị iche iche, enwere naanị anọ ...GỤKWUO -
Acadia Trofinetide Phase III Clinical Top-Line Results Ezi
Na 2021-12-06, oge US, Acadia Pharmaceuticals (Nasdaq: ACAD) kwupụtara nsonaazụ kacha mma nke nnwale ụlọ ọgwụ Phase III nke onye nyocha ọgwụ ya, Trofinetide.Ikpe nke III, nke a na-akpọ ...GỤKWUO -
Ọganihu nyocha nke opioid peptides sitere na nkwado nke Difelikefalin
N'ihe dị ka 2021-08-24, Cara Therapeutics na onye ya na ya na-azụ ahịa Vifor Pharma kwupụtara na FDA kwadoro kappa opioid receptor agonist difelikefalin (KORSUVA™) nke mbụ ya maka ...GỤKWUO -
RhoVac Cancer Peptide Vaccine RV001 ka ụlọ ọrụ ọgụgụ isi nke Canada ga-enweta ikike ya.
Oge Canada 2022-01-24, RhoVac, ụlọ ọrụ na-ahụ maka ọgwụ na-elekwasị anya na immunology tumor, mara ọkwa na ngwa patent ya (Mba. 2710061) maka ọgwụ ogwu peptide cancer RV001 ga-enye ikike site na ...GỤKWUO
